Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vaginal pH modulation refers to the dynamic regulation of vaginal acidity. In healthy women, vaginal pH remains moderately acidic (usually 3.8–4.5), predominantly due to the metabolic activity of Lactobacillus species producing lactic acid from glycogen substrates in the vaginal epithelium[3][4][6]. Estrogen plays a crucial regulatory role by increasing glycogen availability, particularly during the reproductive years, which fuels acid-producing flora and maintains the acidic environment[1][4][6]. Acidic vaginal pH guards against pathogenic infections, supports fertility, and is a marker of reproductive and gynecological health[3][4][6]. A shift toward alkaline pH is linked to bacterial vaginosis, increased infection risk, and reproductive complications[2][3][6]. Mechanisms include not only microbial lactic acid production but also active proton secretion by vaginal epithelial cells, partially via V-type H^+-ATPase activity that is upregulated by estrogen[1]. Vaginal pH modulation is thus a critical physiological homeostatic process rather than an individual therapeutic target (such as a receptor, enzyme, or transporter)[1][3][6]. This entry does not describe a canonical drug target molecule or receptor, but a physiological parameter shaped by multiple factors. For structured target information, a specific molecular entity (e.g., "V-type proton ATPase subunit," "Estrogen receptor," "Lactobacillus species") should be selected instead.
Estrogen increases glycogen content in vaginal epithelial cells, which feeds lactobacilli that produce lactic acid, acidifying the environment[1][4][3][6]. Direct modulation via lactic acid-producing bacteria (Lactobacillus species)[4][6][3]. Inhibition of proton secretion via V-type H^+-ATPase in epithelial cells (targetable by certain agents such as bafilomycin A1 in research models)[1].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal pH modulation.